The number of laparoscopic surgeries and the extent to which they are performed, has been increasing since the late 1980s. According to the U.S. Food and Drug Administration (FDA) more than 2 million laparoscopic procedures are performed in the United States each year - i.e. about 85% of all Cholecystectomies.
Because laparoscopic surgery may involve extreme changes in the patients’ position, extensive periods of intraabdominal carbon dioxide (CO2) insufflation, and difficulty in evaluating the amount of blood loss, anesthesia for laparoscopy is considered a potentially high-risk procedure.
Since laparoscopic procedures may induce serious physiological changes and complications, adequate monitoring must be applied to patients.
The CNAP® technology improves quality and safety for patients undergoing laparoscopic interventions. It provides the anesthesiologist with a wider scope of action through noninvasive, continuous blood pressure monitoring and the possibility for noninvasive hemodynamic optimization (PPV).
- Comfort for patients: noninvasive, thus safe monitoring whilst avoiding the risks of infection of invasive arterial lines
- Easy to use: quick and error-free application for everyday use with minimal training required
- Time and cost saving: fixed start-up-time of 90 seconds combined with reusable sensors
- noninvasive, reliable measurement where invasive arterial lines are not indicated.
Devices designed for laparoscopic surgery: